In last trading session, CureVac N.V (NASDAQ:CVAC) saw 0.77 million shares changing hands with its beta currently measuring 2.53. Company’s recent per share price level of $5.38 trading at -$0.02 or -0.37% at ring of the bell on the day assigns it a market valuation of $1.21B. That closing price of CVAC’s stock is at a discount of -6.32% from its 52-week high price of $5.72 and is indicating a premium of 55.95% from its 52-week low price of $2.37. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.49 million shares which gives us an average trading volume of 1.17 million if we extend that period to 3-months.
For CureVac N.V (CVAC), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.71. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
CureVac N.V (NASDAQ:CVAC) trade information
Upright in the red during last session for losing -0.37%, in the last five days CVAC remained trading in the red while hitting it’s week-highest on Thursday, 06/26/25 when the stock touched $5.38 price level, adding 1.28% to its value on the day. CureVac N.V’s shares saw a change of 51.98% in year-to-date performance and have moved -1.10% in past 5-day. CureVac N.V (NASDAQ:CVAC) showed a performance of 21.17% in past 30-days. Number of shares sold short was 2.6 million shares which calculate 1.37 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 5 to the stock, which implies a fall of -7.6% to its current value. Analysts have been projecting 5 as a low price target for the stock while placing it at a high target of 5. It follows that stock’s current price would jump 7.06% in reaching the projected high whereas dropping to the targeted low would mean a gain of 7.06% for stock’s current value.
CureVac N.V (NASDAQ:CVAC)’s Major holders
Insiders are in possession of 57.37% of company’s total shares while institution are holding 4.70 percent of that, with stock having share float percentage of 11.04%. Investors also watch the number of corporate investors in a company very closely, which is 4.70% institutions for CureVac N.V that are currently holding shares of the company. MILLENNIUM MANAGEMENT LLC is the top institutional holder at CVAC for having 2.87 million shares of worth $9.77 million. And as of 2024-06-30, it was holding 1.2808 of the company’s outstanding shares.
The second largest institutional holder is POINT72 ASSET MANAGEMENT, L.P., which was holding about 2.42 million shares on 2024-06-30. The number of shares represents firm’s hold over 1.0801 of outstanding shares, having a total worth of $8.24 million.
On the other hand, iShares Trust-iShares Core MSCI EAFE ETF and iShares Trust-iShares Biotechnology ETF are the top two Mutual Funds which own company’s shares. As of Apr 30, 2025 , the former fund manager was holding 661.37 shares of worth $3.56 million or 0.29% of the total outstanding shares. The later fund manager was in possession of 600.46 shares on Apr 30, 2025 , making its stake of worth around $3.23 million in the company or a holder of 0.27% of company’s stock.
